News Articles Tagged: Deucravacitinib Clinical Trials

Exploring the Future: Deucravacitinib and its Potential in Autoimmune Diseases

An outlook on Deucravacitinib's therapeutic potential beyond psoriasis, examining ongoing research in Crohn's disease, lupus, and other immune-mediated conditions.

Deucravacitinib Clinical Trials: Evidence of Efficacy and Safety

An overview of the clinical trial data supporting Deucravacitinib's efficacy in psoriasis and its potential for other autoimmune conditions.

The Clinical Journey of Deucravacitinib: Efficacy and Safety in Plaque Psoriasis Treatment

An in-depth look at the clinical trials and real-world data for Deucravacitinib (BMS-986165), a novel oral TYK2 inhibitor. Understand its effectiveness and safety profile for plaque psoriasis patients.